Influence of plasma cortisol and other laboratory parameters on nonalcoholic fatty liver disease

Hormone and Metabolic Research

Volumn 47, Issue 7, 2014, Pages 479-484

  Hubel, J M ^a   Schmidt, S A ^a   Mason, R A ^b   Haenle, M M ^a   Oeztuerk, S ^a   Koenig, W ^a   Boehm, B O ^c   Kratzer, W ^a   Graeter, T ^a   Flechtner Mors, M ^d  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Affairs Medical Center   (United States)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d Institute of Epidemiology Ulm   (Germany)

Author keywords

cortisol; cross sectional study; NAFLD; ultrasonography

Indexed keywords

ALANINE AMINOTRANSFERASE; HYDROCORTISONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; ECHOGRAPHY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; WAIST HIP RATIO; ADOLESCENT; BLOOD; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; TRIGLYCERIDES; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84930210296     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1389982     Document Type: Article

References (40)

1. Cohen J. C., Horton J. D., Hobbs H. H. Human fatty liver disease: old questions and new insights. Science: 2011; 332 1519 1523
2. Bhala N., Jouness R. I., Bugianesi E. Epidemiology and natural history of patients with NAFLD. Curr Pharm Des: 2013; 19 5169 5176
3. Musso G., Gambino R., Cassader M., Pagano G. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med: 2011; 43 617 649
4. Szczepaniak L. S., Nurenberg P., Leonard D., Browning J. D., Reingold L. S., Grungy S., Hobbs H. H., Dobbins R. L. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab: 2005; 288 E462 E468
5. WHO Expert Committee on Physical Status. The Use and Interpretation of Anthropometry: report of a WHO expert committee (WHO technical report series): World Health Organisation Genf: 1995; 427 437
6. Charatcharoenwitthaya P., Lindor K. D. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis: 2007; 11 37 54
7. Hamaguchi M., Kojima T., Itoh Y., Fujii K., Nakajiama T., Kato T., Takeda N., Okuda J., Ida K., Kawahito Y., Yoshikawa T., Okanoue T. The severity of ultrasonographic findings in non-alcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol: 2007; 12 2708 2715
8. Mendez-Sanchez N., Arrese M., Zamora-Valdes D., Uribe M. Current concepts in the pathogenesis of nonalcoholoic fatty liver disease. Liver Int: 2007; 27 423 433
9. Mishra P., Younossi Z. M. Abdominal Ultrasound for Diagnosis of Non-alcoholic Fatty liver Disease (NAFLD). Am J Gastroenterol: 2007; 102 2716 2717
10. Westerbacka J., Lammi K., Hakkinen A. M., Rissanen A., Salminen I., Aro A., Yki-Järvinen H. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab: 2005; 90 2804 2809
11. Tamura S., Shimomura I. Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest: 2005; 115 1139 1142
12. McDevitt R. M., Bott S. J., Harding M., Coward W. A., Bluck L. J., Prentice A. M. De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women. Am J Clin Nutr: 2001; 47 737 746
13. Hudgins L. C., Hellerstein M., Seidman C., Neese R., Diakun J., Hirsch J. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest: 1996; 97 2081 2091
14. Schwarz J. M., Linfoot P., Dare D., Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr: 2003; 77 43 50
15. Stanhope K. L., Schwarz J. M., Keim N. L., Griffin S. C., Bremer A. A., Graham J. L., Hatcher B., Cox C. L., Dyachenko A., Zhang W., McGahan J. P., Seibert A., Kraus R. M., Chiu S., Schaefer E. J., Ai M., Otokazawa S., Nakajima K., Nakano T., Beysen C., Hellerstein M. K., Berglund L., Havel P. J. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest: 2009; 119 1322 1334
16. Buechler C., Wanninger J., Neumeier M. Adiponectin, a key adipokine in obesity related liver diseases. World J Gastroenterol: 2011; 17 2801 2811
17. Schwimmer J. B., Celedon M. A., Lavine J. E., Salem R., Campbell N., Schork N. J., Shiehmorteza M., Yokoo T., Chavez A., Middleton M. S., Sirlin C. B. Heritability of nonalcoholic fatty liver disease. Gastroenterology: 2009; 136 1585 1592
18. Hooper A. J., Adams L. A., Burnett J. R. Genetic determinants of hepatic steatosis in man. J Lipid Res: 2011; 52 593 617
19. Ahmed A., Rabbitt E., Brady T., Brown C., Guest P., Bujalska I. J., Newsome P. N., Hubscher S., Elias E., Adams D. H., Tomlinson J. W., Stewart P. M. A switch in hepatic cortisol metabolism across the spectrum of non-alcoholic fatty liver disease. PloS One: 2012; 7 e29531
20. Zelber-Sagi S., Nitzan-Kaluski D., Halpern T., Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int: 2006; 26 856 863
21. Bedogni G., Bellentani S., Miglioli L., Masutti F., Passalacqua M., Castiglione A., Tribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology: 2006; 6 33l
22. Browning J. D., Szczepaniak L. S., Dobbins R., Nuremberg P., Horton J. D., Cohen J. C., Grundy S. M., Hobbs H. H. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology: 2004; 40 1387 1395
23. CHEn C. H., Huang M. H., Yang J. C., Nien C. K., Yang C. C., Yeh Y. H., Yueh S. K. Prevalence of risk factors of nonalcoholic fatty liver disease in adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese results. J Clin Gastroenterol: 2006; 40 745 752
24. Fan J. G. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol: 2013; 28 01 11 17
25. Amarapurkar D. N., Hashimoto E., Lesmana L. A., Sollano J. D., Chen P. J., Goh K. L. Asia-Pacific Working Party on NAFLD How common is non-alcoholic fatty liver disease in the Asia-Pacific region and there local differences? J Gastroenterol Hepatol: 2007; 22 788 793
26. Bellentani S., Scaglioni F., Marino M., Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis: 2010; 28 155 161
27. Fabbrini E., Conte C., Magkos F. Methods for assessing intrahepatic fat content and steatosis. Curr Opin Clin Nutr Metab Care: 2009; 12 474 481
28. Dasarathy S., Dasarathy J., Khiyami A., Joseph R., Lopez R., McCullough A. J. Validity of real ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol: 2009; 51 1061 1067
29. Kratzer W., Kron M., Hay B., Pfeiffer M. M., Kächele V. Prevalence of cholelithiasis in South Germany - an ultrasound study of 2498 persons of a rural population. Z Gastroenterol: 1999; 37 1157 1162
30. Shen L., Fan J. G., Shao Y., Zeng M. D., Wang J. R., Luo G. H., Li J. Q., Chen S. Y. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol: 2003; 9 1106 1110
31. Clark J. M. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastrenterol: 2006; 40 01 S5 S10
32. Dourakis S. P., Sevastianos V. A., Kaliopi P. Acute severe steatohepatitis related to prednisolone therapy. Am J Gastrenterol: 2002; 97 1074 1075
33. Dolinsky V. W., Douglas D. N., Lehner R., Vance D. E. Regulation of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone. Biochemical J: 2004; 378 967 974
34. Targher G., Bertolini L., Rodella S., Zoppini G., Zenari L., Falezza G. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. Clin Endocrinol: 2006; 64 337 341
35. Konopelska S., Kienitz T., Hughes B., Pirlich M., Bauditz J., Lochs H., Strasburger C. J., Stewart P. M., Quinkler M. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis. Clin Endocrinol Oxf: 2009; 70 554 560
36. CANdia R., Riquelme A., Baudrand R., Carvajal C. A., Morales M., Solis N., Pizarro M., Escalona A., Carrasco G., Boza C., Pérez G., Padilla O., Cerda J., Fardella C. E., Arrese M. Overexpression of 11β-hydroxysteroid dehydrogenease type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease. Liver Int: 2012; 32 392 399
37. Shiina Y., Homma Y. Relationships between the visceral fat area on CT and coronary risk factor markers. Intern Med: 2013; 52 1775 1780
38. Debono M., Prema A., Hughes T. J., Bull M., Ross R. J., Newell-Price J. Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma. J Clin Endocrinol Metab: 2013; 98 2383 2391
39. Ayonrinde O. T., Olynyk J. K., Beilin L. J., Mori T. A., Pennell C. E., de Klerk N., Oddy W. H., Shipman P., Adams L. A. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology: 2011; 53 800 809
40. Speliotes E. K., Massaro J. M., Hoffmann U., Vasan R. S., Meigs J. B., Sahani D. V., Hirschhorn J. N., O'Donell C. J., Fox C. S. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology: 2010; 51 1979 1987